Diagnostics of Primary Immunodeficiency Diseases: A Sequencing Capture Approach

被引:61
作者
Moens, Lotte N. [1 ]
Falk-Sorqvist, Elin [1 ]
Asplund, A. Charlotta [2 ]
Bernatowska, Ewa [3 ]
Smith, C. I. Edvard [2 ]
Nilsson, Mats [1 ,4 ]
机构
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Huddinge, Sweden
[3] Childrens Mem Hlth Inst, Dept Clin Immunol, Warsaw, Poland
[4] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, S-10691 Stockholm, Sweden
关键词
IMMUNE-DEFICIENCY; MUTATIONS; GLYCOSYLATION; DESIGN; PROBES;
D O I
10.1371/journal.pone.0114901
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Primary Immunodeficiencies (PID) are genetically inherited disorders characterized by defects of the immune system, leading to increased susceptibility to infection. Due to the variety of clinical symptoms and the complexity of current diagnostic procedures, accurate diagnosis of PID is often difficult in daily clinical practice. Thanks to the advent of "next generation'' sequencing technologies and target enrichment methods, the development of multiplex diagnostic assays is now possible. In this study, we applied a selector-based target enrichment assay to detect disease-causing mutations in 179 known PID genes. The usefulness of this assay for molecular diagnosis of PID was investigated by sequencing DNA from 33 patients, 18 of which had at least one known causal mutation at the onset of the experiment. We were able to identify the disease causing mutations in 60% of the investigated patients, indicating that the majority of PID cases could be resolved using a targeted sequencing approach. Causal mutations identified in the unknown patient samples were located in STAT3, IGLL1, RNF168 and PGM3. Based on our results, we propose a stepwise approach for PID diagnostics, involving targeted resequencing, followed by whole transcriptome and/or whole genome sequencing if causative variants are not found in the targeted exons.
引用
收藏
页数:15
相关论文
共 25 条
[1]   Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency [J].
Al-Herz, Waleed ;
Bousfiha, Aziz ;
Casanova, Jean-Laurent ;
Chatila, Talal ;
Conley, Mary Ellen ;
Cunningham-Rundles, Charlotte ;
Etzioni, Amos ;
Franco, Jose Luis ;
Gaspar, H. Bobby ;
Holland, Steven M. ;
Klein, Christoph ;
Nonoyama, Shigeaki ;
Ochs, Hans D. ;
Oksenhendler, Erik ;
Picard, Capucine ;
Puck, Jennifer M. ;
Sullivan, Kate ;
Tang, Mimi L. K. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[2]   Agammaglobulinemia: causative mutations and their implications for novel therapies [J].
Berglof, Anna ;
Turunen, Janne J. ;
Gissberg, Olof ;
Bestas, Burcu ;
Blomberg, K. Emelie M. ;
Smith, C. I. Edvard .
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (12) :1205-1221
[3]  
Blundred RM, 2011, EXPERT REV CLIN IMMU, V7, P169, DOI [10.1586/ECI.10.93, 10.1586/eci.10.93]
[4]   RNF168 ubiquitylates 53BP1 and controls its response to DNA double-strand breaks [J].
Bohgaki, Miyuki ;
Bohgaki, Toshiyuki ;
El Ghamrasni, Samah ;
Srikumar, Tharan ;
Maire, Georges ;
Panier, Stephanie ;
Fradet-Turcotte, Amelie ;
Stewart, Grant S. ;
Raught, Brian ;
Hakem, Anne ;
Hakem, Razqallah .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (52) :20982-20987
[5]   Practice parameter for the diagnosis and management of primary immunodeficiency [J].
Bonilla, FA ;
Bernstein, IL ;
Khan, DA ;
Ballas, ZK ;
Chinen, J ;
Frank, MM ;
Kobrynski, LJ ;
Levinson, AI ;
Mazer, B ;
Nelson, RP ;
Orange, JS ;
Routes, JM ;
Shearer, WT ;
Sorensen, RU .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (05) :S1-S63
[6]   Multiplex amplification enabled by selective circularization of large sets of genomic DNA fragments [J].
Dahl, F ;
Gullberg, M ;
Stenberg, J ;
Landegren, U ;
Nilsson, M .
NUCLEIC ACIDS RESEARCH, 2005, 33 (08) :1-7
[7]   Next-generation sequencing: ready for the clinics? [J].
Desai, A. N. ;
Jere, A. .
CLINICAL GENETICS, 2012, 81 (06) :503-510
[8]  
Etzioni A, 2014, PRIMARY IMMUNODEFICIENCY DISORDERS: A HISTORIC AND SCIENTIFIC PERSPECTIVE, P1
[9]   Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing [J].
Evans, Barbara J. .
GENETICS IN MEDICINE, 2013, 15 (12) :915-920
[10]  
Freeman A., 2014, PRIMARY IMMUNODEFICI, P489